Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri.

@article{Scialli2000IntermittentLA,
  title={Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri.},
  author={Anthony R Scialli and A Jonathen Levi},
  journal={Fertility and sterility},
  year={2000},
  volume={74 3},
  pages={
          540-6
        }
}
OBJECTIVE To evaluate the feasibility of intermittent 6-month courses of leuprolide acetate for the long-term control of symptoms attributed to leiomyomata uteri. DESIGN Prospective open-label feasibility study. SETTING University department of obstetrics and gynecology. PATIENT(S) Thirty women with abnormal bleeding or discomfort (pain or pressure) due to leiomyomata uteri. INTERVENTION(S) Patients received an initial 6-month course of the GnRH agonist leuprolide acetate, after which… CONTINUE READING
BETA